GLP-1 injection therapy is delivered weekly via a virtually painless injection
Most data is extrapolated from individual peptide trials and animal models
View 5-Amino-1MQ Products Mechanism How 5-Amino-1MQ Works Research Mechanism Preclinical research suggests 5-Amino-1MQ inhibits NNMT, affecting nicotinamide metabolism and NAD+ availability in studied cell types
Rapid weight loss can lead to muscle loss if strength training and adequate protein intake are not prioritized during the GLP-1 journey
While the study was observational (meaning that causality cant be confirmed), it does add to the growing body of evidence suggesting that its worth investigating these weight-loss drugs as potential cancer prevention tools, says lead author, Professor Elizabeth McDonald
The enterotrophic peptide hormone glucagon-like peptide 2 (GLP-2) was shown to abrogate OS and improve intestinal antioxidant capacity by reducing LPS-induced increases in intestinal IL-1 and oxidized glutathione levels (267) and increasing intestinal SOD activity and reduced-glutathione levels (268, 269) ( Supplementary Table 1 )
